LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 Mitoxantrone
3.33
uM
LJP5
0.2312 0.0236 -0.2789 0.0639
SK-BR-3 Mitoxantrone
3.33
uM
LJP6
0.2147 0.0398 -0.3078 0.0957
SK-BR-3 MK2206
3.33
uM
LJP6
0.5486 0.0156 0.2502 0.0263
SK-BR-3 Neratinib
3.33
uM
LJP5
0.3170 0.0343 -0.1434 0.1185
SK-BR-3 Nilotinib
3.33
uM
LJP5
1.0798 0.0272 1.1311 0.0416
SK-BR-3 Nintedanib
3.33
uM
LJP6
0.7593 0.0313 0.6004 0.0519
SK-BR-3 NU7441
3.33
uM
LJP5
0.7783 0.0316 0.6338 0.0470
SK-BR-3 Dactolisib
3.33
uM
LJP5
0.3775 0.0067 -0.0375 0.0618
SK-BR-3 NVP-TAE684
3.33
uM
LJP6
0.5067 0.0470 0.1746 0.1009
SK-BR-3 Palbociclib
3.33
uM
LJP6
0.7112 0.0258 0.5220 0.0297
SK-BR-3 PD0325901
3.33
uM
LJP5
0.6523 0.0036 0.4208 0.0321
SK-BR-3 PD0325901
3.33
uM
LJP6
0.6538 0.0257 0.4277 0.0180
SK-BR-3 PD173074
3.33
uM
LJP6
1.0569 0.0430 1.0939 0.0719
SK-BR-3 PD184352
3.33
uM
LJP5
1.0040 0.0248 1.0028 0.0386
SK-BR-3 Pelitinib
3.33
uM
LJP5
0.3693 0.0365 -0.0511 0.0886
SK-BR-3 PF431396
3.33
uM
LJP5
0.3861 0.0143 -0.0205 0.0367
SK-BR-3 PF477736
3.33
uM
LJP5
0.3057 0.0291 -0.1567 0.0820
SK-BR-3 PF562271
3.33
uM
LJP6
0.3645 0.0119 -0.0570 0.0432
SK-BR-3 PHA-665752
3.33
uM
LJP5
0.9849 0.0293 0.9806 0.0468
SK-BR-3 PHA-793887
3.33
uM
LJP6
0.3592 0.0246 -0.0643 0.0398
SK-BR-3 PI103
3.33
uM
LJP6
0.3576 0.0330 -0.0736 0.1031
SK-BR-3 PLX-4720
3.33
uM
LJP5
0.7736 0.0248 0.6183 0.0604
SK-BR-3 QL-X-138
3.33
uM
LJP6
0.4288 0.0043 0.0486 0.0495
SK-BR-3 QL-XII-47
3.33
uM
LJP6
0.2682 0.0159 -0.2225 0.0948
SK-BR-3 Radicicol
3.33
uM
LJP5
0.4020 0.0135 0.0043 0.0541